Prednisolone Eye Drop Recall Information
The FDA has issued a recall affecting certain lots of Prednisolone Acetate Ophthalmic Suspension, USP, 1%. These prescription eye drops are commonly used to treat inflammation following eye surgery and for other inflammatory eye conditions.
Patients of Eye Center of Northern Colorado who are currently using prednisolone eye drops should review the FDA recall information to determine whether their prescription is affected.
Which Eye Drops Are Being Recalled?
The recall applies only to specific lots of Prednisolone Acetate Ophthalmic Suspension, USP, 1%, manufactured by Lupin Limited. Not every bottle of prednisolone eye drops is included.
The FDA has classified this as a Class II recall, meaning the affected product could potentially cause temporary or treatable health effects. According to the FDA, the risk of serious health consequences is considered low.
Why Were the Eye Drops Recalled?
According to the FDA, the recall was initiated because of the potential presence of a foreign substance in certain bottles of the medication.
The recall was issued out of an abundance of caution to help protect patient safety.
What Should Patients Do?
If you currently use prescription prednisolone eye drops, check your medication to determine whether it is included in the recall.
If your eye drops are on the recall list, contact the prescribing physician for a replacement.
To view the complete list of affected lot numbers and expiration dates, visit the FDA’s official recall announcement.
Our Commitment to Patient Safety
Medication recalls can understandably be concerning, but they are an important part of ensuring the safety of patients. We encourage all patients using prescription eye medications to stay informed about FDA safety announcements and recalls.
At Eye Center of Northern Colorado, we’re committed to keeping our patients informed about important medication safety updates. If you have questions about your eye care or need to schedule an appointment, our team is happy to assist.
